- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Cystic fibrosis (CF)
- Meeting Date: March 2025
- Public Summary Document (PSD) March 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2025 PBAC Meeting - (Word)
Ivacaftor – March 2025
Ivacaftor; Sachet containing granules 13.4 mg; Kalydeco®
Last updated
12 March 2025